Effect of tranexamic acid on transfusion requirement in dual antiplatelet-treated anemic patients undergoing off-pump coronary artery bypass graft surgery-a randomized controlled study

Circulation Journal

Volumn 76, Issue 1, 2012, Pages 96-101

  Ahn, So Woon ^a   Shim, Jae Kwang ^b,c   Youn, Young Nam ^b   Song, Jong Wook ^b   Yang, So Young ^b   Chung, Sung Chan ^b   Kwak, Young Lan ^b,c,d  

^a Kwandong University College of Medicine   (South Korea)

^b Department of Anesthesiology and Pain Medicine ^*  (South Korea)

^c Anesthesia and Pain Research Institute   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Anemia; Dual antiplatelet therapy; Off pump coronary artery bypass; Tranexamic acid

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FRESH FROZEN PLASMA; HEMOGLOBIN; PLACEBO; SODIUM CHLORIDE; TRANEXAMIC ACID;

AGED; ANEMIA; ARTICLE; BLOOD CONSERVATION; BLOOD TRANSFUSION; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; OPERATION DURATION; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE PERIOD; PLASMA TRANSFUSION; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT;

AGED; ANEMIA; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; COMORBIDITY; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; TIME FACTORS; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84255183883     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0811     Document Type: Article

References (30)

1. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial. JAMA 2010; 304: 1559-1567.
2. Scott BH, Seifert FC, Glass PS, Grimson R. Blood use in patients undergoing coronary artery bypass surgery: Impact of cardiopulmonary bypass pump, hematocrit, gender, age, and body weight. Anesth Analg 2003; 97: 958-963.
3. Salisbury AC, Alexander KP, Reid KJ, Masoudi FA, Rathore SS, Wang TY, et al. Incidence, correlates, and outcomes of acute, hospital- acquired anemia in patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2010; 3: 337-346.
4. Kapetanakis EI, Medlam DA, Petro KR, Haile E, Hill PC, Dullum MK, et al. Effect of clopidogrel premedication in off-pump cardiac surgery: Are we forfeiting the benefits of reduced hemorrhagic sequelae? Circulation 2006; 113: 1667-1674.
5. Angiolillo DJ, Ueno M, Goto S. Basic principles of platelet biology and clinical implications. Circ J 2010; 74: 597-607.
6. Sellke FW, Chu LM, Cohn WE. Current state of surgical myocardial revascularization. Circ J 2010; 74: 1031-1037.
7. Song SW, Youn YN, Yi G, Lee S, Yoo KJ. Effects of continuous administration of clopidogrel before off-pump coronary artery bypass grafting in patients with acute coronary syndrome. Circ J 2008; 72: 626-632.
8. Chassot PG, van der Linden P, Zaugg M, Mueller XM, Spahn DR. Off-pump coronary artery bypass surgery: Physiology and anaesthetic management. Br J Anaesth 2004; 92: 400-413.
9. Valeri CR, Cassidy G, Pivacek LE, Ragno G, Lieberthal W, Crowley JP, et al. Anemia-induced increase in the bleeding time: Implications for treatment of nonsurgical blood loss. Transfusion 2001; 41: 977-983.
10. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs 1985; 29: 236-261.
11. Wei M, Jian K, Guo Z, Wang L, Jiang D, Zhang L, et al. Tranexamic acid reduces postoperative bleeding in off-pump coronary artery bypass grafting. Scand Cardiovasc J 2006; 40: 105-109.
12. Mezzano D, Panes O, Munoz B, Pais E, Tagle R, Gonzalez F, et al. Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure. Thromb Haemost 1999; 82: 1250-1254.
13. Senay S, Toraman F, Karabulut H, Alhan C. Efficiency of preoperative tranexamic Acid in coronary bypass surgery: An analysis correlated with preoperative clopidogrel use. Heart Surg Forum 2010; 13: E149-E154.
14. Weber CF, Gorlinger K, Byhahn C, Moritz A, Hanke AA, Zacharowski K, et al. Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy. Eur J Anaesthesiol 2011; 28: 57-62.
15. Vanek T, Jares M, Fajt R, Straka Z, Jirasek K, Kolesar M, et al. Fibrinolytic inhibitors in off-pump coronary surgery: A prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). Eur J Cardiothorac Surg 2005; 28: 563-568.
16. Shim JK, Choi YS, Oh YJ, Bang SO, Yoo KJ, Kwak YL. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing offpump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2007; 134: 59-64.
17. Nesher N, Alghamdi AA, Singh SK, Sever JY, Christakis GT, Goldman BS, et al. Troponin after cardiac surgery: A predictor or a phenomenon? Ann Thorac Surg 2008; 85: 1348-1354.
18. Molitoris BA, Levin A, Warnock DG, Joannidis M, Mehta RL, Kellum JA, et al. Improving outcomes from acute kidney injury. J Am Soc Nephrol 2007; 18: 1992-1994.
19. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990; 76: 1680-1697.
20. Hartmann M, Sucker C, Boehm O, Koch A, Loer S, Zacharowski K. Effects of cardiac surgery on hemostasis. Transfus Med Rev 2006; 20: 230-241.
21. Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U, et al. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008; 34: 73-92.
22. Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention: Cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation: Review and meta-analysis. J Intern Med 2005; 257: 399-414.
23. Mehta SR, Yusuf S. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J 2000; 21: 2033-2041.
24. Bertrand OF, Larose E, Rodes-Cabau J, Rinfret S, Dery JP, Bagur R, et al. Incidence, range, and clinical effect of hemoglobin changes within 24 hours after transradial coronary stenting. Am J Cardiol 2010; 106: 155-161.
25. de Haan J, van Oeveren W. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: Protection by aprotinin. Thromb Res 1998; 92: 171-179.
26. Murphy GJ, Mango E, Lucchetti V, Battaglia F, Catapano D, Rogers CA, et al. A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 2006; 132: 475-480, 480, e471-e478.
27. Adler Ma SC, Brindle W, Burton G, Gallacher S, Hong FC, Manelius I, et al. Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: A systematic review and meta-analysis. J Cardiothorac Vasc Anesth 2011; 25: 26-35.
28. Kirklin J, Barratt-Boyes B. Cardiac surgery. New York: Churchill Livingstone, 1986.
29. Karski J, Djaiani G, Carroll J, Iwanochko M, Seneviratne P, Liu P, et al. Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: A prospective randomized controlled clinical trial. J Thorac Cardiovasc Surg 2005; 130: 309-314.
30. Kon ZN, Brown EN, Grant MC, Ozeki T, Burris NS, Collins MJ, et al. Warm ischemia provokes inflammation and regional hypercoagulability within the heart during off-pump coronary artery bypass: A possible target for serine protease inhibition. Eur J Cardiothorac Surg 2008; 33: 215-221.